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Abstract
Therapeutic resistance of cerebral secondary tumours largely depends on unique aspects linked to the neurovascular
unit, especially cerebral endothelial cells and astrocytes. By using advanced microscopy techniques, here we explored
novel mechanisms related to the neurovascular unit during extravasation and proliferation of triple negative breast
cancer cells in the brain. Metastatic mammary carcinoma cells arrested and elongated within one hour in cerebral
microvessels, but their number decreased by almost 80% in the first two days. Interestingly, malignant cells induced
vasoconstriction and development of intraluminal endothelial plugs, which isolated invading cells from the circulation.
During diapedesis – which usually took place on day four and five after inoculation of the tumour cells – continuity of
cerebral endothelial tight junctions remained intact, indicating migration of cancer cells through the transcellular
pathway. In addition, metastatic cells induced formation of multiluminal vessels and claudin-5-positive endothelial
blebs. However, even severe endothelial blebbing could be reversed and the vessel morphology was restored shortly
after the tumour cells completed transendothelial migration. Similar to neuro-inflammatory leukocytes, tumour cells
migrated not only through the endothelial layer, but through the glia limitans perivascularis as well. Nevertheless,
along with the growth of metastatic lesions by co-option of pre-existing capillaries, astrocytes and astrocyte end-feet
were gradually expelled from the vessels to the border of the tumour. Taken together, we identified previously
unknown mechanisms involved in the reaction of brain resident cells to invading breast cancer cells. Our results
contribute to a better understanding of the complex cross-talk between tumour cells and host cells in the brain, which
is essential for the identification of new therapeutic targets in this devastating disease.
Keywords: Apoptotic and non-apoptotic blebbing, Astrocyte end-foot, Brain metastasis, Cerebral endothelial cell,
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Introduction
Brain metastases, most often originating from lung
cancer, breast cancer and melanoma, have a particu-
larly dismal prognosis. Despite significant therapeutic
advances in extracranial malignancies, management
of brain metastases is still an unmet clinical chal-
lenge. Several mechanisms may be responsible for
the ineffective treatment strategies, including exclu-
sion of systemic agents by the blood-brain barrier
(BBB) [17], dense vascularization of the brain [35]
and protective effects of astrocytes on tumour cells
[42]. Nevertheless, cells of the neurovascular unit
(NVU) have a decisive role in the fate of brain meta-
static tumour cells [40].
The concept of the NVU emerged to emphasize the
unique intimate relationship between brain cells and the
cerebral vasculature [12]. Regulated by input from pericytes,
glial cells and neurons, cerebral endothelial cells (CECs)
take the centre stage of the NVU to form and maintain the
BBB. In contrast to peripheral endothelial cells, CECs are
connected to each other by continuous tight junctions
(TJs), formed by transmembrane proteins like claudin-5 or
occludin and a cytoplasmic plaque. Brain metastatic cells
have to take up the challenge of opening or overcoming
this tight endothelial barrier before diapedesis through
brain microvessels. Accordingly, tumour cells spend several
days arrested in the lumen of cerebral capillaries before
© The Author(s). 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
* Correspondence: krizbai.istvan@brc.mta.hu; wilhelm.imola@brc.mta.hu
†István A. Krizbai and Imola Wilhelm contributed equally and both should be
considered as last authors.
1Institute of Biophysics, Biological Research Centre, Hungarian Academy of
Sciences, Temesvári krt. 62, Szeged 6726, Hungary
Full list of author information is available at the end of the article
Haskó et al. Acta Neuropathologica Communications           (2019) 7:133 
https://doi.org/10.1186/s40478-019-0788-1
migrating through the vessel wall [19], despite the severe
stress they are exposed to in the blood stream [32]. It is
largely unknown what changes are induced in the endothe-
lium during this long time spent by the tumour cells
intravascularly. Using in vitro and ex vivo methods, we have
previously shown that metastatic cells may up-regulate ex-
pression of N-cadherin and mesenchymal markers in CECs
during a process called endothelial-mesenchymal transition
(EndMT), which can facilitate transmigration of the tumour
cells [16]. EndMT is indeed a long-lasting process, which
was seen after 2 days in CECs exposed to factors secreted
by melanoma or breast cancer cells. Ex vivo, we detected
endothelial N-cadherin upregulation in the vicinity of ex-
travasating breast cancer cells and close to the growing
metastatic lesions at later time points; however, breast can-
cer cells migrated through the cerebral endothelium in an
N-cadherin-independent manner [10].
Diapedesis itself has been even less characterized in in
vivo/ex vivo models. It was suggested to take place ex-
clusively from capillaries [19] with the tumour cell being
pinched at the transmigration hole on the vessel wall
[15]. CECs were shown to extend protrusions covering
extravasating mammary carcinoma cells [10], indicating
active involvement of the endothelium. However, several
questions remain to be answered. What are the changes
induced in the cerebral endothelium by tumour cell ex-
travasation in vivo? Is tumour cell-induced endothelial
dysfunction reversible or irreversible? Is there any endo-
thelial apoptosis, proliferation or any type of new vessel
formation taking place during initial steps of brain me-
tastasis formation?
After completing transvascular migration, metastatic
cells can only survive in the brain environment if at-
tached to the abluminal surface of the vessel wall [3]. By
this time, tumour cells come in contact with other cells
of the NVU. Immediate and persistent peritumoural
astrogliosis and microglial reactions are the most im-
portant in this respect [40]. It is not known, however,
how the glia limitans perivascularis is affected in initial
and later phases of brain metastasis formation. Vascular
changes during metastatic outgrowth – except for vessel
co-option – also need better understanding.
By using real-time in vivo and ex vivo microscopy,
here we aimed at unravelling morphological and func-
tional changes in cerebral vessels and cells of the NVU
before, during and after transmigration of breast cancer
cells through the BBB.
Material and methods
Cell culture and in vitro models
4T1 mouse triple negative mammary carcinoma cells
were kept in Roswell Park Memorial Institute (RPMI)
1640 medium (Pan Biotech, Aidenbach, Germany) sup-
plemented with 5% foetal bovine serum (FBS, PAA
Laboratories, Linz, Austria) and Glutamax (Thermo Fi-
scher Scientific, Waltham, MA, USA). 4T1 cells were
transfected with pcDNA3.1(+)/Luc2 = tdT plasmid using
Lipofectamine 2000 (Thermo Fischer Scientific) and
underwent single-cell cloning, after sorting of red fluor-
escent cells using a BD FACSAria Fusion flow cytometer
(BD Biosciences, San Jose, CA, USA). The media of
tdTomato-4T1 cells contained 500 μg/ml G418 (Thermo
Fischer Scientific) for further selection and maintenance
of red fluorescence. Emerald GFP-expressing EmGFP-
4T1 cells were obtained by retroviral transfection and
selected on blasticidin S (Sigma-Aldrich, St. Louis, MO,
USA). All cell lines were regularly tested for mycoplasma
contamination using the MycoAlert Mycoplasma Detec-
tion Kit (Lonza, Basel, Switzerland). Only mycoplasma-
negative cultures were used for experiments.
Venus-YFP-expressing primary mouse brain endothelial
cells (MBECs) were isolated from 6- to 8-week-old FVB/
Ant:TgCAG-yfp_sb #27 female mice (obtained from Insti-
tute of Experimental Medicine, Budapest, Hungary). After
collection of the brains, the meninges were removed and
cerebral cortices were cut into small pieces and digested
in two steps with collagenase and collagenase/dispase.
Microvessel fragments were collected after 10min 1000 · g
centrifugation on Percoll (Sigma-Aldrich) gradient, and
plated onto fibronectin/collagen-coated dishes. Endothe-
lial cells growing out of the microvessels were cultured in
DMEM/F12 (Thermo Fisher Scientific), 10% plasma-de-
rived serum (PDS, First Link, Birmingham, UK) and
growth factors. In the first two days, 4 μg/ml puromycin
(Sigma-Aldrich) was added to remove contaminating cells.
YFP-MBECs and tdTomato-4T1 cells were used for
endothelial-tumour cell co-cultures. First, we cultured
endothelial cells on the abluminal side of the filter in-
serts (Corning-Costar Transwell Clear, Corning, NY,
USA, #3450) coated with collagen. Tumour cells were
seeded on the luminal side in a number of 4.5 · 104/cm2
and co-cultured for 48 h.
Experimental animals and surgeries
All surgeries were carried out on 8-week old female
BALB/c (The Jackson Laboratory) or FVB/Ant:TgCAG-
yfp_sb #27 mice. Before every procedure, mice were
anaesthetized via inhaled isoflurane 4% (v/v) in oxygen
for induction and 1–2% (v/v) for maintenance, from a
precision vaporizer (Open Circuit Isoflurane Tabletop
System, Stoelting, Dublin, Ireland). Depth of anaesthesia
was monitored by toe pinch tests.
For all intravital experiments, cranial windows were
used to obtain optical access to the cortex. Briefly, anaes-
thetized animals were mounted on a stereotaxic frame
incorporating a heating pad. Craniotomy (d = 3.5mm) was
performed over the right parietal cortex with a micro drill
(H.MH-170, High Speed Rotary Handpiece, Foredom,
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Blackstone Industries, Bethel, CT, USA) fitted with a 0.5
mm burr, followed by the removal of the dura. In some
experiments, astrocytes were labelled by topical applica-
tion of 10 μM SR101 (Sigma-Aldrich) in Ringer-HEPES
solution for 2–3min before the window installation. A
coverslip of 5 mm diameter was then placed over the ex-
posed brain and the edge of the glass was sealed with
cyanoacrylate glue. An aluminium plate was glued onto
the skull for head fixation. The exposed bone and the alu-
minium bar were covered with cyanoacrylate glue and
dental cement (Unifast III, GC Europe, Leuven, Belgium)
to increase stability. A recovery period of at least one
month was allowed between implantation of the cranial
window and intravital microscopy observation of endothe-
lial-tumour cell interactions. Astrocyte-tumour cell inter-
actions were investigated in a time frame of 30min to 2 h
after cranial window installation due to the temporary
astrocyte staining. After recovery, either 106 tdTomato-
4T1 cells were inoculated into the right common carotid
artery or 3 · 106 tdTomato-4T1 cells were injected intra-
cardially into FVB/Ant:TgCAG-yfp_sb #27 female mice
with chronic cranial window for two-photon microscopy,
or without craniotomy for ex vivo investigations. BALB/c
female mice were intracardially injected with 3 · 106
EmGFP-4T1, then 1 day, 5 days or 10 days later cranial
window was installed right before two-photon microscopy
imaging.
For ex vivo observations, surgically untouched FVB/
Ant:TgCAG-yfp_sb #27 mice received 3 · 106 tdTomato-
4T1-cells intracardially. Certain animals were subjected
to in vivo proliferation assay and treated intraperitone-
ally with 5-ethynyl-2′-deoxyuridine (EdU, Thermo
Fisher Scientific, 100 mg/kg), a thymidine analogue, 24 h
before tissue collection. After 1, 3, 5, 8 or 10 days, ani-
mals were anaesthetized and transcardially perfused with
phosphate buffered saline (PBS, 10 mM, pH = 7.4), then
with Karnovsky’s fixative (for electron microscopy) or
3% paraformaldehyde (for immunofluorescence) in PBS.
Brains were removed and post-fixed by immersion in
the same fixative at 4 °C overnight. The following day,
the fixative was replaced with PBS (for vibratome sec-
tion) or 30% sucrose solution in 0.1 M phosphate buffer
(PB, for frozen sections), and the brains were stored at
4 °C until further processing.
Intravital two-photon imaging
Mice were anaesthetized with isoflurane and kept on a heat-
ing system-incorporated stereotaxic stage. The head was
immobilized and positioned via the attached aluminium bar.
This stable positioning and the unique pattern of the super-
ficial pial vasculature allowed us to image the same cortex
volume over days. Intravital microscopy was carried out
with a FEMTO2DAlba microscope (Femtonics, Budapest,
Hungary) using a 20x or 60x large working distance water
immersion objective using MES software (v4.6.2336,
Femtonics). Two-photon excitation was performed using a
Mai Tai HP Ti-sapphire laser (Spectra-Physics, San Jose,
CA, USA) at 810 nm, which was found optimal for EmGFP
and CellTracker Red CMTPX excitation and also adequate
for SR101 and at 900 nm, which optimally excited both
tdTomato and Venus-YFP. Laser power was set to 10–40%
depending on the depth of imaging (0–400 μm from the
brain surface). Emission wavelengths were collected by
GaAsP photomultipliers. Larger volumes (x: 500 μm; y:
500 μm; z: 250 μm) were recorded with 3 μm vertical steps
to evaluate the cell number changes and dynamics of
tumour cell intravascular location in the first 48 h following
inoculation. To acquire sufficient red fluorescence signal,
tdTomato-4T1 cells were also stained with CellTracker Red
CMTPX (Thermo Fisher Scientific) for this experimental
setup. ImageJ’s “3D Object Counter” plugin was used to
assess the changes [1]. High magnification z-stack images (x:
120 μm; y: 120 μm; z: 120 μm, with 1 μm steps) were re-
corded for studying cell morphology changes and transmi-
gration and no additional labelling of 4T1-tdTomato was
applied. Image stacks were auto-levelled, merged and con-
verted to RGB colour in Fiji [28].
Immunofluorescence and fluorescence microscopy
After fixation, the whole brain was mounted for freezing
microtome (Reichert-Jung, Leica Biosystems, Wetzlar,
Germany) or vibratome (Leica Biosystems) sectioning and
sliced coronally. 50 μm brain sections were collected and
stored in PBS with 0.05% sodium azide. Antigen retrieval
was either omitted or performed by incubating slices at
85 °C for 60min in PBS. Permeabilization was performed
with 0.5% TritonX-100 in PBS for 30min at room
temperature, followed by blocking with 3% BSA (bovine
serum albumin) in PBS. Primary antibody solutions were
prepared in 3% BSA and 0.5% TritonX-100-containing
PBS. Sections were incubated overnight under slow nuta-
tion. The following antibodies were used on vibratome
sections: anti-AQP4 (1:100, Santa Cruz Biotechnology,
Santa Cruz, CA, USA, #sc-20,812), anti-claudin-5 (1:100,
Thermo Fisher Scientific, #35–2500), anti-cleaved cas-
pase-3 (1:50, Cell Signaling, Boston, MA, USA, #9661,),
anti-collagen IV (1:100, Abcam, Cambridge, UK, #ab6586)
and anti-PECAM-1 (1:120, Novus Biologicals, Centennial,
CO, USA, #NB100–2284); on frozen sections: anti-fibro-
nectin (1:100, Abcam, #ab2413), anti-GFAP (1:100,
Abcam, #ab7260) and anti-Iba-1 (1:100, Abcam, #ab5076).
Sections were extensively washed in PBS, and the second-
ary antibody solution was afterward applied on them for
60min at room temperature in the dark. Alexa Fluor 488,
594, 647 anti-rabbit, anti-mouse and anti-goat IgG
(Jackson ImmunoResearch, Cambridgeshire, UK and
Thermo Fisher Scientific) and STAR RED anti-mouse IgG
(Abberior, Göttingen, Germany) were used as secondary
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antibodies in a dilution of 1:300–1:600 in 3% BSA-con-
taining PBS. Sections were then washed with PBS, coun-
terstained with a colour compatible nuclear staining
(Hoechst 33342, Sigma-Aldrich) for 5 min, washed again
with PBS, rinsed in water and mounted with an aqueous
fluorescent mounting solution, FluoroMount-G media
(SouthernBiotech, Birmingham, AL, USA). Visualization
of nuclei with DNA synthesis was performed on sections
from EdU-treated animals using Click-iT Plus EdU Alexa
Fluor 647 Imaging Kit (Thermo Fischer Scientific)
following the manufacturer’s instructions. ImageJ’s “3D
Object Counter” plugin was used for manual assessment
of EdU-positive tumour cells.
Immunohistochemistry and immunofluorescence were
visualized with Leica SP5 and Leica SP8 confocal laser
scanning microscopes with 63x and 100x oil immersion ob-
jectives or a STED (stimulated emission depletion) super-
resolution-capable STEDYCON (Abberior Instruments,
Göttingen, Germany) built on an Axio Observer Z1
inverted epifluorescence microscope (Zeiss, Oberkochen,
Germany) equipped with an alpha Plan-Apochromat 100x/
1.46 oil immersion objective.
Preparation of ultrathin sections and transmission
electron microscopy (TEM)
TdTomato-4T1-bearing FVB/Ant:TgCAG-yfp_sb #27
mouse brains were sectioned using a VT1000S (Leica
Biosystems) vibratome. 100 μm sections were col-
lected and post-fixed for 5 h in Karnovsky’s fixative
at room temperature. After post-fixation, sections
were cut into 1–2 mm2 pieces. Specimens containing
tdTomato-4T1 cells were selected for further pro-
cessing. Samples were rinsed and post-fixed in 2%
OsO4. After dehydration with a graded series of
ethanol, the samples were embedded in epoxy resin
(Durcupan ACM, Sigma-Aldrich) and polymerized at
55 °C for 48 h. Ultrathin sections (50 nm) were
prepared with an Ultracut UCT (Leica Biosystems)
and contrasted with 2% uranyl acetate (Electron
Microscopy Sciences, Hatfield, PA, USA) and 2%
lead citrate (Electron Microscopy Sciences), then
analysed with a JEM-1400Flash transmission electron
microscope (JEOL, Tokyo, Japan) fitted with an 8
MP Matataki Flash CCD camera (JEOL).
Western-blot
4T1-tdTomato cells and YFP-Venus MBECs were co-cul-
tured for 48 h on the two sides of the filter inserts and
lysed separately in radioimmunoprecipitation assay buffer.
After 30min incubation on ice, cell lysates were centri-
fuged at 13,000 · g for 15min at 4 °C. Protein concentra-
tion was determined with bicinchoninic acid (BCA) (Santa
Cruz Biotechnology). Laemmli buffer was added to the
samples, followed by heating at 95 °C for 3min. Prepared
samples were electrophoresed using standard denaturing
SDS-PAGE procedures and blotted on polyvinylidene
difluoride (0.2 μm pore size from Bio-Rad, Hercules, CA,
USA and the 0.45 μm pore size from BioTrace, Pall
Corporations, Port Washington, NY, USA) membranes
(β-actin and fibronectin, respectively). Afterwards, the
non-specific binding capacity of the membranes was
blocked with 3% BSA or 5% non-fat milk in TBS-T (Tris-
buffered saline with 0.1% Tween-20). Membranes were
incubated with primary antibodies diluted in TBS-T: anti-
β-actin (1:1000, Santa Cruz Biotechnology, #sc-47,778) or
fibronectin (1:1000, Abcam, #ab2413). Blots were washed
in TBS-T three times for 10min. Horseradish peroxidase
(HRP)-conjugated secondary antibodies were diluted in
TBS-T as follows: 1:3000 anti-rabbit IgG and anti-mouse
IgG (Jackson ImmunoResearch) and added for 1 h and
then washed again in TBS-T. Immunoreaction was
visualized with Clarity Chemiluminescent Substrate (Bio-
Rad, Hercules, CA, USA) in a ChemiDoc MP System
(Bio-Rad). Densitometry analysis was performed with the
Image Lab Software, version 5.2 (Bio-Rad).
Results
Metastatic breast cancer cells arrest and elongate rapidly
in cerebral microvessels
As a unique feature of brain metastasis formation [40],
tumour cells spend several days in cerebral capillaries
before proceeding to diapedesis through the vessel wall
[19]. During this phase [15], metastatic cells may
change their initial resting position in the vascular
lumen. By monitoring the same brain regions in living
mice using intravital two-photon microscopy, we ex-
plored the number of tumour cells/cell clusters disap-
pearing, changing position and remaining in resting
phase in the first 48 h after inoculation of triple nega-
tive, tdTomato-expressing 4T1 breast cancer cells. The
relatively large volume scanned with the consequently
lower magnification, and the lack of nuclear staining
did not allow for clear detection of morphology changes
and determination of the number of tumour cells in an
intravascular cell cluster. However, we could still assess
that metastatic cells gained an elongated morphology
already within 1 h after the injection of tumour cells
into the arterial circulation (Fig. 1a). Some cells
remained in the same position for two days, while
others changed their initial location and disappeared
from or appeared in the scanned volumes (Fig. 1a and
b). The number of initially arrested tumour cells/cell
clusters (imaged at 1 h after tumour cell inoculation)
decreased to 74.21 ± 21.95% at 5 h, to 38.21 ± 31.60% at
24 h and to 21.64 ± 5.59% at 48 h (Fig. 1b), as detected
by monitoring the same three regions in the parietal
cortex of three mice each by two-photon microscopy.
We next wanted to assess the time of final arrest of the
Haskó et al. Acta Neuropathologica Communications           (2019) 7:133 Page 4 of 15
tumour cells, i.e. when they reached their resting pos-
ition, from where they did not move inside the capillary
lumen anymore. We found that 33.09 ± 26.97% of the
cells adhered in the first hour, 31.33 ± 30.23% arrested
between 1 h and 5 h and the remaining 35.58 ± 28.18%
of the cells attached to the luminal side of the endothe-
lium between 5 h and 24 h, and remained in the same
location by 48 h post-inoculation (Fig. 1b). The surviv-
ing cells did not change their position after 24 h. These
numbers indicate that the firm cell arrest happens in
the first 24 h and, most probably, the majority of the
cells find their long-term intravascular location in the
initial hours.
Tumour cells arrested preferentially in vascular branch-
ing points (Fig. 1c) and left the junctions intact in the first
4 days, as assessed by PECAM-1 (platelet and endothelial
cell adhesion molecule) (Additional file 1: Figure S1) and
claudin-5 immunostainig (Fig. 1d) and TEM (Additional
Fig. 1 Arrest of breast cancer cells in the cerebral vasculature. a: Representative two-photon microscopy z-projection images of tdTomato-4T1
cells arrested in the cerebral microvasculature of FVB/Ant:TgCAG-yfp mice. The same region of the same mouse was imaged at all time points.
a1-a4: tdTomato-4T1 cells; b1-b4: merged red (tdTomato-4T1) and green (Venus-YFP-labelled endothelial cells) channels. Arrow indicates the
same cell at all time points. Encircled region shows cells changing position. b: Quantitative representation of breast cancer cells arrested in the
brain 1 h, 5, 24 and 48 h after inoculation (first panel). Percentage of surviving cells finding the final position in the vascular lumen in the first
hour, between 1 and 5 h and between 5 and 24 h (second panel). N = 3 animals, n = 3 brain regions (500 · 500 · 250 μm3 x · y · z) of each animal.
c: Representative two-photon micrograph (z-projection) of tdTomato-4T1 cells arrested at a vascular branching point in the parietal cortex (5 h
after inoculation). Arrows indicate elongated tumour cells. d: Claudin-5 immunostaining (grey) at 4 days after the injection of tdTomato-4T1 cells
into the circulation of mice having Venus-YFP-labelled endothelial cells; confocal z-projection. Arrows indicate endothelial nuclei protruded into
the lumen; dashed arrow shows dilated capillary. e: Tumour cell arrested in a pial artery in two-photon micrographs (z-projections) captured at 4
and 5 days after inoculation, respectively. Red = tumour cells (tdTomato), green = endothelium (YFP), blue = nuclei (Hoechst)
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file 1: Figure S2). Breast cancer cells have been previously
found to arrest exclusively in microvessels (capillaries and
post-capillary venules) of the brain [19]. Outside the brain
parenchyma, we could find breast cancer cells stuck in
subarachnoid large vessels; however, these cells never
elongated and disappeared after a few days without ex-
travasation (Fig. 1e).
Arrested metastatic cells induce vasoconstriction,
endothelial plug formation and obstruction of cerebral
microvessels
After 24–48 h spent in the lumen of parenchymal vessels,
mammary carcinoma cells induced vasoconstriction and
formation of endothelial plugs, which protruded into the
lumen both upstream and downstream of the cancer cells
(Fig. 2a). High-resolution confocal microscopy images in-
dicated both partial and complete obstructions of the vas-
cular lumen in the neighbourhood of the tumour cells
(Fig. 2b). We could clearly see complete vessel obstruction
by the tumour cell-induced plug in living animals as well,
in a series of two-photon microscopy optical cross-sec-
tions (Fig. 2c). When tumour cells arrested at vascular
branching points, vessels in all directions were obstructed
by plugs and constrictions (Figs. 1d and 2d).
By examining 6–9 cancer cells/animal in the brains of
10 tumour-inoculated mice using confocal microscopy,
we assessed the prevalence of vascular obstructions in
the neighbourhood of the cancer cells on day 4 after in-
oculation. Majority of the tumour cell-containing micro-
vessels were completely (61.03%) or partially (23.90%)
closed by endothelial plugs. In addition, 9.01% of them
were obstructed by vasoconstriction and only 6.06%
remained open. These numbers indicate that it is a gen-
eral phenomenon in brain capillaries that tumour cells
are isolated by endothelial cells from the circulation.
Plugs of protruded endothelial bodies contained
the nuclei of the endothelial cells (Fig. 2e). We hy-
pothesized that these plugs were formed by endothe-
lial division; however, endothelial nuclei in the plugs
were EdU negative (Fig. 2f). As a positive control,
we detected EdU-positive endothelial cells not in-
volved in plug formation and not coming in contact
with carcinoma cells (Additional file 1: Figure S3).
Therefore, tumour cell-associated plugs were formed
as the result of endothelial reorganization and not
cell division. In addition, overexpression of abnor-
mally localized claudin-5 and PECAM-1 was ob-
served in plug-forming endothelial cells (Additional
file 1: Figure S4 and S5), suggesting junctional
reorganization and possibly compromised endothelial
polarity. Interestingly, a large part of the intralum-
inal tumour cells was EdU positive (Fig. 2f) at each
time point assessed: 62.50% at 24 h, 51.85% at 3 days
and 40.54% at 5 days after tumour cell injection.
Despite the high prevalence of EdU-positive intra-
luminal tumour cells, no increase in tumour cell
number was observed from 24 h to days 3 or 5.
Supposedly, some of the intravascular tumour cells
became polyploid/multinucleated, which could help
their survival and metastasis formation [22]. These
large cells formed in the capillary lumen after day 3,
dilated the vessel, as shown in Fig. 1d.
In the vicinity of the plugs and intravascular tumour cells,
accumulation of matrix proteins was observed in the
lumen, like type 4 collagen (Fig. 2g) and fibronectin
(Fig. 2h). Besides the possible contribution of circulating
matrix proteins [38], fibronectin was also overexpressed in
the tumour cells (Fig. 2i and j). Tumour cells expressed
even more fibronectin after completing the diapedesis
(Additional file 1: Figure S6).
Extravasation occurs either via small pores or through
large openings on the vessel wall, through the
transcellular pathway, often from multiluminal vessels
After 3–8 days spent attached to the luminal surface of
the cerebral endothelium, typically on day 4 or 5, meta-
static cells contracted and migrated through the vessel
wall into the brain parenchyma. Interestingly, we
observed a few transmigrating tumour cells that were
proliferating/EdU positive (Additional file 1: Figure S7).
In contrast to the long time spent intravascularly,
the diapedesis itself was relatively rapid, completed
in a few hours and was accompanied by resolution
of the obstructions (Fig. 3a). Our two-photon and
confocal microscopy investigations revealed two
types of transvascular migration. Metastatic breast
cancer cells either diapedesed through small pores
(Fig. 3a, b and c) or large discontinuities opened on
the vessel wall (of 10 μm diameter in average)
(Figs. 2d and 3d). By observing 14 transmigrations in
the brains of living animals using two-photon mi-
croscopy, we counted 10 diapedesis events which oc-
curred through pores < 5 μm (71.43%) and 4 through
large fenestrations (28.57%).
Using in vitro models, we have previously shown
that breast cancer cells are able to migrate transcel-
lularly, leaving the TJs intact [10]. Here we explored
this possibility in our mouse model, and found that
continuity of TJs, represented by claudin-5 staining,
remained intact in the vicinity of transmigrating cells
(Fig. 3e). This suggests that breast cancer cells are
able to take the transcellular route of transmigration
through the BBB in vivo.
Another phenomenon that we observed was that cancer
cells induced formation of additional vascular channels
(Fig. 3f-h). Multiluminal vessels containing several channels
or chambers (ranging from a few up to 15) were observed
in 5 of 14 (35.71%) transmigrations tracked in two-photon
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Fig. 2 Vascular changes induced by metastatic cells before extravasation into the brain parenchyma. a: Two-photon micrograph (z-projection) of
an endothelial plug (arrow) and vascular constriction (dotted arrow) in the neighbourhood of an arrested breast cancer cell, on day 5 after
tumour cell injection. b: Confocal z-projection of endothelial plugs completely (arrow) or partially (dotted arrow) obstructing the cerebral capillary
up- and downstream of an arrested metastatic cell (day 4 after inoculation). c: Complete obstruction of the vessel lumen by the tumour cell-
induced endothelial plug in 3D (i) and cross-section (ii-v) two-photon microscopy images (day 5). Arrow indicates tumour cell-induced plug
formation in different optical slices. Dotted arrow points to a capillary not affected by cancer cells. d: 3D representation (i) and z-sections (ii-vii) of
endothelial plugs (arrows) and vasoconstriction (dotted arrow) closing all capillary branches in the proximity of a transmigrating tumour cell
(arrowhead) (confocal micrograph, day 5). e: Confocal z-projection indicating the endothelial nucleus in the plug (arrow) obstructing the capillary
next to the cancer cell. f: EdU-positivity (grey) of intraluminal tumour cell, but not of endothelial nucleus in the plug (confocal z-projection). g:
Up-regulation of collagen secretion (arrow, grey) in the neighbourhood of arrested carcinoma cells (confocal z-projection). Dashed arrows
indicate endothelial blebs. h: Up-regulation of fibronectin secretion (FN, grey) in the neighbourhood of arrested carcinoma cells (confocal z-
projection, arrows). Dashed arrows indicate basal fibronectin expression in non-affected capillaries. i: Representative western-blot image of
fibronectin expression in mouse brain endothelial (MBEC) and tdTomato-4T1 cells in mono- and co-culture. B-actin was used as loading control. j:
Fibronectin protein levels normalized to β-actin in co-cultured vs. mono-cultured MBECs and tdTomato-4T1 cells (average ± SD) (western-blot
quantification). N = 3 independent experiments. * P < 0.05 (t-test). Red = tumour cells (tdTomato), green = endothelium (YFP),
blue = nuclei (Hoechst)
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Fig. 3 Extravasation of triple negative mammary carcinoma cells into the brain. a: Transmigration of a tdTomato-4T1 cell through a small pore in a
constricted capillary on day 4 after inoculation of the tumour cells. Representative z-projection of a two-photon micrograph. 7 h later, the extravasation
is completed and the tumour cell is attached to the extraluminal surface of the vessel. b: Cross-section representation of the transendothelial
migration of a breast cancer cell through a small pore (arrow) on day 4 after inoculation of the tumour cells. The shown two-photon microscopy
images (i, ii) are optical sections of the same tumour cell. c: Confocal z-sections (i-iii) of a tumour cell migrating out of a multiluminal vessel on day 4
after inoculation of the tumour cells. Arrow indicates transmigration pore observed on a single optical section (ii). d: Transmigration through a large
opening on the vessel wall, as represented in two-photon microscopy z-sections (i-iii). e: Claudin-5 staining (grey) of intact TJs in the neighbourhood
of a tumour cell (arrow) extravasating from a cerebral capillary (confocal z-projection). Dashed arrow indicates a claudin-5-positive bleb on the
basolateral side of the endothelium. f: Representative two-photon micrograph of a tumour cell (arrow) migrating through the wall of a multiluminal
vessel, represented in longitudinal section. Dashed arrow indicates the collateral lumen. g: Two-photon microscopy cross-sections (i-iii) of a capillary
having multiple lumens. Arrow indicates extravasating tumour cell. h: Confocal microscopy cross-sections (i-ii) of a capillary having multiple lumens.
Arrow indicates extravasating tumour cell. Dashed arrow shows an endothelial plug. Red = tumour cells (tdTomato), green = endothelium (YFP)
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microscopy. Smaller transmigration pores were formed on
the thinned wall of one of the tubes of the multichannelled
endothelium. Besides splitting of the capillary, rarely, we
could see the growth of a collateral bypassing the tumour
cell-bearing vessel (Additional file 1: Figure S8).
Diapedesis of cancer cells is accompanied by blebbing of
both tumour and endothelial cells
Migration of the tumour cells through the cerebral
endothelium was frequently accompanied by blebbing of
metastatic and/or endothelial cells (Fig. 4a-h). Intensive
blebbing of intravascular tumour cells (Fig. 4a-c) was
frequent, observed in 11 of 14 transmigrations (78.57%)
imaged in two-photon microscopy. During extravasation,
cancer cells usually protruded their blebbing membrane
part through the transmigration pore (Fig. 4a and b),
while the nucleus was left behind in the lumen and got
through the vessel wall in the terminal stage of the dia-
pedesis. Blebbing tumour cells often released extracellu-
lar vesicles (Fig. 4c), resembling large oncosomes [21].
In the neighbourhood of extravasating cancer cells, endo-
thelial blebbing (Figs. 2g, 3e and 4d-h) was similar in fre-
quency to tumour cell blebbing, present in 11 of 14 events
observed by two-photon microscopy (78.57%) and in 10 of
the 11 cases of tumour blebbing (90.91% overlap). Ranging
from a few extraluminal blebs (Figs. 2g, 3e, 4e and f) to
moderate or intensive vacuolization (Fig. 4d, g and h), bleb-
bing of CECs was always linked to the presence of the
tumour cells. Endothelial blebs were claudin-5 positive,
while the endothelium still showed a continuous claudin-5
staining marking the intact TJs (Fig. 4f). Even severe endo-
thelial blebbing could be reversed and the vessels were
restored in 1–2 days after the tumour cells completed
transendothelial migration (Fig. 4g).
Besides the non-apoptotic blebbing of the cerebral
endothelium described above, which is most probably
an important element of the active involvement of
CECs in metastatic extravasation, signs of apoptotic
blebbing and endothelial cell death could also be de-
tected. On the one hand, we observed degenerated
mitochondria in blebbing endothelial cells (Fig. 4h). On
the other hand, we saw cleaved caspase-3-positive
endothelial cells in the neighbourhood of carcinoma
cells (Fig. 4i and j). However, this was a relatively rare
event, observed in 5 of 21 cases in day 4. Endothelial
active caspase-3 staining usually appeared in vesicle-like
structures, showing the typical morphology of cell
death. We assume that endothelial cell death might
provide passage for the tumour cells through the
formation of large openings on the vessel wall. The ma-
jority of tumour cells were usually cleaved caspase-3
negative (Fig. 4i); however, in 5 of 21 cases, we detected
apoptotic tumour cells as well in day 4 (Fig. 4j).
Tumour cells migrate through the glia limitans
perivascularis, but exclude astrocytes from the growing
metastatic lesion
As a next step, interactions of tumour cells with astro-
cytes and especially astrocyte end-feet were investigated
during and after the extravasation. We observed that the
extravasated part of breast cancer cells passed the glia
limitans perivascularis right after breaching the endothe-
lial wall, as our in vivo (Fig. 5a) and ex vivo (Fig. 5b-d)
observations indicate. During extravasation, carcinoma
cells opened the glia limitans formed by an almost con-
tinuous layer of astrocyte end-feet covering the extra-
luminal surface of the vessels (Fig. 5a). Tumour cells
reaching an extraluminal position remained attached to
the vessel wall, incorporating astrocyte end-feet, as
shown in TEM (Fig. 5b) and confocal microscopy images
(Fig. 5c and d). Both the astrocyte-specific glial fibrillary
acidic protein (GFAP) and the end-foot marker aquapo-
rin-4 (AQP4) were localized between the partly or com-
pletely extravasated tumour cell and the capillary
endothelium.
After migrating through the capillary wall, tumour
cells started to divide by co-opting one or two capillar-
ies, which developed an abnormal, disorganized, bent
morphology (Additional file 1: Figure S9). Tumour cells
proliferated rapidly; however, endothelial proliferation
was almost never observed (Additional file 1: Figure
S10), suggesting that blood supply of the tumours was
primarily provided by vascular co-option and not neo-
angiogenesis. As metastatic lesions were growing, astro-
cytes were expelled from the tumour mass (Fig. 5e and
Additional file 1: Figure S11). In parallel, reactive astro-
cytes surrounding metastatic lesions gradually retracted
their end-feet from the vessels to the parenchymal
border of the tumour, which gained a discontinuous
end-foot coverage (Fig. 5f). It should be noted that the
tumour-covered endothelium still showed a continuous
claudin-5 staining, indicating the presence of complete
TJs in the absence of the perivascular astrocyte sheath
(Fig. 5g). We have also observed activated microglia [30]
surrounding transmigrating and extravasated, but not
intravascular cancer cells (Additional file 1: Figure S12).
Discussion
The microenvironment is increasingly recognized as a
profound determinant of tumour progression and thera-
peutic outcome. Composed of neurons, glial and vascular
cells and protected by the BBB, the brain environment is
very special, generally able to host only a few cancer types.
Among these, triple negative breast cancer is one of the
most relevant, having the worst outcome among mam-
mary carcinoma subtypes [13].
Due to the complex anatomy and intercellular com-
munication network, in vitro models are less suitable
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to study mechanisms related to the brain environ-
ment. In addition, early steps of brain metastasis
development cannot be observed in human, because
of the detection limit of current diagnostic tools.
Xenograft models are devoid of a full immune
response, while injection of tumour cells into the
brain parenchyma is not recapitulating the extravasa-
tion step [34]. Therefore, we applied an in vivo ani-
mal model and followed the interactions of brain
resident cells with metastatic breast carcinoma cells.
Since only a limited number of metastatic lesions
were observed in the peripheral organs of the mice,
our in vivo setup is a relevant model of brain metas-
tasis formation with the condition that tumour het-
erogeneity and interspecies differences (translation
from mouse to human) are not addressed.
Among cells of the NVU, CECs and astrocytes are the
most active in immediately responding to and continu-
ously associating with invading tumour cells [15, 19].
Both CECs and astrocytes have a Janus-faced attitude,
bearing both tumour-destructive and -protective mecha-
nisms [40]. Much less is known about the role of peri-
cytes, which regulate the permeability of the blood-
tumour barrier [20] and contribute to connective tissue
accumulation in the metastases [33].
During the long-lasting arrest in the lumens of
cerebral capillaries, several changes may take place
both in cancer and in endothelial cells. EndMT is
one mechanism, the development of which is a slow
process, lasting for a few days [16]. EndMT is char-
acterized by loss of TJ proteins, switch from VE- to
N-cadherin and up-regulation of mesenchymal
markers, like collagen, fibronectin and α-smooth
muscle actin. We have previously described up-regu-
lation of N-cadherin in CECs of tumour cell-hosting
capillaries; however, N-cadherin proved to be dis-
pensable for the extravasation of breast cancer cells
[10]. Here we observed no reduction in the
expression of claudin-5 – the protein forming the
backbone of endothelial TJs – throughout the meta-
static process. Although we saw up-regulation of
extracellular matrix proteins, which are also markers
of EndMT; however, mainly in tumour and not in
endothelial cells. Therefore, we conclude that
EndMT is probably not a mandatory mechanism in-
volved in extravasation of triple negative mammary
carcinoma cells to the brain, at least in mouse.
Although the extravasation occurred late (after 4–5
days or even later), surviving and finally diapedesing
cells reached their final position in the capillary lumen
early (in the first 24 h). The majority of arrested tumour
cells disappeared in the first 2 days. Time-dependent re-
duction of the number of arrested tumour cells may be a
consequence of mechanical stress, anoikis or immune at-
tacks [32]. Mechanical stress may be primarily caused by
deformation of the tumour cells in the narrow vessels,
because fluid shear is practically completely excluded by
the obstruction of the lumen by the tumour cell itself
and the endothelial plugs, described here. Flow may not
only induce shear stress, but may also influence different
steps of tumour cell extravasation. In a zebrafish model,
reduced flow was found to promote early arrest of
tumour cells, while increased flow enhanced extravasa-
tion because integrin-dependent adhesion forces rapidly
exceeded shear forces [9]. Therefore, isolation of tumour
cells from the blood flow may have complex conse-
quences on the metastatic process.
According to our results, anoikis seems to be a rare
event, since we could seldom find cleaved caspase-3-
positive tumour cells. Cell death was also rarely
observed in endothelial cells coming in contact with
cancer cells, leading to the formation of large outlets
for extravasation of the tumour cells through the ves-
sel wall. However, the majority of metastatic transmi-
grations occurred through small (< 5 μm) pores. In
more than one third of the cases, the lowest resistance
(See figure on previous page.)
Fig. 4 Blebbing of metastatic and endothelial cells of cerebral vessels. a: Representative two-photon micrograph (z-projection) of a blebbing
breast cancer cell (arrow) migrating from the lumen of the capillary to the brain parenchyma. Dotted arrow indicates vasoconstriction. b: 3D
confocal image representation of a blebbing metastatic cell projecting out the blebs through the vessel wall during initial phase of
transendothelial migration. c: Confocal microscopy z-projection indicating blebs detaching from the tumour cell (red) resulting in large
oncosome-like vesicles (arrows). d: Endothelial apoptotic blebbing during diapedesis of a metastatic cell (arrow) through the capillary wall, as
represented in two-photon microscopy z-sections (i-iii). e: Basolateral blebs (arrows) in endothelial cells of a cerebral capillary hosting a breast
cancer cell, as represented in confocal microscopy z-sections (i-ii). f: Claudin-5-positivity (grey) of endothelial blebs (arrows). STED (claudin-5) and
confocal (blue, green and red channels) z-projection images are shown. g: Two-photon micrograph (z-projection) presenting intensive blebbing
of cerebral microvessels during transmigration of cancer cells. Arrow indicates blebbing, dashed arrow shows extravasating tumour cell. 36 h later,
the tumour cell reached an extravascular position (arrowhead), while intensive blebbing is almost completely resolved. Numbers indicate
matching vessels in the two images. h: Transmission electron micrograph of a cerebral capillary and an intravascular tumour cell. Insets show
mitochondrial damage (1) and blebbing (2) of the endothelium. EC = endothelial cell. i: Vesicle-like cleaved caspase-3 positivity (grey) in
endothelial cells close to metastatic cells, as shown in a confocal z-projection. Arrows indicate cleaved caspase-3-positive endothelial cells, dashed
arrows mark tumour cells. j: Cleaved caspase-3 positivity (grey) of endothelial cells and metastatic cells, as shown in a confocal z-stack. Arrow
indicates cleaved caspase-3 positivity in endothelial cells, dashed arrows mark cleaved caspase-3-positive tumour cells. Red = tumour cells
(tdTomato), green = endothelium (YFP), blue = nuclei (Hoechst)
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Fig. 5 Interaction of metastatic cells with astrocytes and proliferation in the brain parenchyma. a: Two-photon microscopy z-projections
indicating a metastatic breast cancer cell (green) breaking the glia limitans perivascularis. SR101-positive astrocytes are marked in red; asterisks
indicate cell bodies of astrocytes. Capillaries are delineated by end-feet of astrocytes; arrow indicates disruption of the continuity in the glia
limitans during extravasation of the tumour cell. b: Transmission electron micrograph showing an extravasated tumour cell attached to the
extraluminal surface of a cerebral capillary (day 5). Inset (1) highlights astrocyte end-foot (arrow) between the tumour cell and the capillary
endothelium. c: Representative confocal z-projections showing GFAP-positive astrocyte end-feet covering capillaries in initial phases of diapedesis
of metastatic cells. Red = tumour cells (tdTomato), green = endothelium (YFP), blue = nuclei (Hoechst), grey = GFAP. d: Confocal z-projection
showing AQP4-positive astrocyte end-feet co-opted by extravasated metastatic cells. Merged image of blue (nuclei), green (endothelium), red
(tumour cells) and grey (AQP4) channels. e: Astrocytes expelled from the growing metastatic lesion on day 10 after inoculation, as shown in a
two-photon z-projection image. Red = astrocytes (SR101), green = tumour cells (EmGFP). f: AQP4-positive astrocyte end-feet gradually retracted
from the capillary wall to the surface of the metastatic tumour. Confocal z-projection of metastatic lesions from the brain of an animal on day 10.
Red = tumour cells (tdTomato), green = endothelium (YFP), blue = nuclei (Hoechst), grey = AQP4. Arrows show vascular AQP4 staining, dotted
arrows indicate absence of vascular AQP4 staining, while arrowheads point to AQP4 staining on the surface of the tumour. g: Intact TJs in vessels
co-opted by growing metastatic tumours on day 10 after, as shown in a confocal z-projection image. Red = tumour cells (tdTomato), green =
endothelium (YFP), blue = nuclei (Hoechst), grey = claudin-5
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point through which the diapedesis took place was
found by the tumour cell after the development of
multichannelled capillaries. Using in vitro models, we
have previously shown that brain endothelial cells
extend filopodia-like membrane protrusions towards
breast cancer cells, incorporating them and facilitat-
ing the transcellular route of transendothelial
migration [10]. Endothelial protrusions covering ex-
travasating cells were seen in vivo as well [10], and
this seems to be the mechanism of the formation of
multiple channels within a vessel. This type of trans-
migration has been previously described as “endothe-
lial covering-type extravasation” in a zebrafish model
of HeLa tumour formation [14] and “endothelization”
in a mouse pulmonary melanoma metastasis model
[18, 26].
In fact, the process of endothelial protrusion formation
and consequent multilumination of the vessel resembles
the first step of intussusceptive angiogenesis [5], when
endothelial bridges are formed [25]. Collateral capillaries
spanning the tumour cell-affected vessel may form through
this mechanism. However, according to our observations,
the main tumour vascularization mechanism [41] in mouse
brain metastases is vessel co-option. During this process,
cancer cells proliferate attached to the abluminal surface of
already existing capillaries [15] interacting with the base-
ment membrane [3, 36].
It is still a question of debate whether tumour cell migra-
tion through the vessel wall induces a reversible or irrevers-
ible damage of the endothelium. Using an in vitro model,
we have previously suggested that melanoma cells induce
apoptosis of CECs [8]. However, melanoma and breast can-
cer cells seem to have a distinct behaviour in the brain,
showing different transmigration efficiencies and routes
(paracellular of melanoma and mainly transcellular of
breast cancer) [10, 23]. Here we observed that triple nega-
tive breast cancer cells might induce endothelial death in
the mouse brain during their extravasation; however, more
often, the endothelium could recover even from severe
structural changes. These changes included blebbing of the
endothelial cell membrane, which was observed with a fre-
quency of almost 80% in the neighbourhood of tumour
cells. Blebbing is usually associated with apoptosis [4];
however, non-apoptotic membrane blebbing has also been
described in a wide variety of cell types in response to mul-
tiple stimuli [7]. Non-apoptotic endothelial blebbing has
been observed in oxidative stress [37] and adhesion [24].
The role of endothelial bleb formation in the metastatic
process remains to be elucidated. Moreover, it is also not
clear whether the extent of blebbing (from a few basolateral
vacuoles to complete restructuration of the vessel wall) has
any impact on the tumour cells.
Nevertheless, blebbing involves rearrangement of the
membrane and the cytoskeleton, a process dependent on
the Rho family of small GTPases, especially activation of
Rho-kinase (ROCK) [7]. In apoptotic cells, activation of
ROCK by caspase-3 seems to be responsible for bleb forma-
tion [29]. In addition, ROCK activation has also been linked
to tumour cell motility. In line with this, we frequently ob-
served tumour cell blebbing during extravasation in the
brain. Generally, the blebbing membrane of the tumour cell
was the first to squeeze through the vessel wall, followed by
the cytoplasm and the nucleus. The bleb-associated mode of
tumour cell motility that does not require proteolysis and is
associated with a rounded cell morphology, the so-called
amoeboid migration, is dependent on ROCK activation [27].
However, our previous in vitro results indicated that foster-
ing the amoeboid migration by Rac inhibition hampers not
only melanoma, but also breast cancer cell transmigration
through brain endothelial monolayers [23, 39]. It remains to
be established how small GTPase signalling and blebbing in
endothelial and tumour cells affect breast cancer brain
metastasis formation.
Another interesting observation of our study is that
tumour cells breach the glia limitans perivascularis during
their extravasation. This is important because immune cells
– diapedesis of which is used as a reference in deciphering
mechanisms of extravasation of tumour cells [26, 31] – also
have to migrate through the glia limitans perivascularis to
induce neuro-inflammation [6, 11]. However, as a meta-
static lesion is growing, AQP4-positive astrocyte end-feet
are disappearing from the vessel to cover the surface of the
tumour, from which reactive astrocytes are completely ex-
pelled. Since in parallel with vanishing from the capillaries,
AQP4 accumulates at the border of the tumour, we con-
clude that this is rather an extraction of astrocyte end-feet
from the vessels than loss of polarization, as previously sug-
gested [20]. Interestingly, claudin-5 staining of the vessels
remained continuous even after loss of direct contact with
astrocyte end-feet, probably due to the presence of pericytes
[2]. Indeed, disappearance of astrocyte foot processes from
metastatic vessels did not show any correlation with the
permeability [20]. Although we cannot exclude the possibil-
ity that some vessels become leaky due to partial opening
of the TJs, our results suggest that this is not mandatory in
brain metastatic lesions.
Conclusions
By using advanced microscopy techniques – including
monitorization of tumour cell movements in the brains
of living animals – we observed novel mechanisms re-
lated to cells of the NVU, namely CECs and astrocytes,
in brain metastasis formation of triple negative mam-
mary carcinoma. These mechanisms include:
-isolation of the invading cell from the circulation by
vessel obstruction and formation of multiluminal
vessels;
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-tumour cell-induced blebbing of endothelial cells
followed by recovery after completion of
transmigration;
-transcellular migration of tumour cells through single
brain endothelial cells and breaching of the glia
limitans perivascularis;
-retraction of astrocyte end-feet from the co-opted
vessel to the surface of the tumour with preserved TJ
integrity of CECs.
Although it is largely unclear which of these are
pro- and which are anti-metastatic, the large number
of transmigration-related phenomena may explain
the difficulty in finding a therapeutic target in this
devastating disease.
Additional file
Additional file 1: Figure S1. Intact PECAM-1 staining in the proximity
of arrested metastatic cells. Figure S2. Preserved TJs in the proximity of a
metastatic cell engaged to transendothelial migration. Arrows indicate
intact TJs. Transmission electron micrographs. Images (1) and (2) are
higher magnifications of insets shown in first panel. Figure S3.
Proliferating endothelial cell in a cerebral capillary distant to tumour cells.
Arrow indicates an EdU-positive endothelial cell. Figure S4. Claudin-5
staining of the plug-forming endothelium. Figure S5. PECAM-1 staining
in CECs involved in plug formation. Figure S6. Up-regulated expression
of fibronectin (FN) by a tumour cell extravasated into the brain
parenchyma. Figure S7. Diapedesing EdU-positivetumour cell. Arrow
indicates transmigration pore on the capillary wall. Figure S8. Collateral
capillary (arrow) bridging the vessel damaged by a metastatic cell. Two-
photon micrograph (z-stack). Figure S9. Tortuous vessels in brain
metastatic tumours as shown in two-photon (1) and confocal (2) z-
projections. Co-option of two capillaries is shown in (1). Figure S10.
Proliferating tumour, but not endothelial cells in the metastatic lesion on
day 10 after inoculation. Figure S11. Exclusion of astrocytes from the
growing tumour in the brain. Two-photon microscopy z-section of image
presented in Fig. 5f. Merged image of green (tumour, EmGFP) and red
(SR101-positive astrocytes) channels. Arrows point to astrocyte end-feet
localized outside the tumours, dashed arrow indicates astrocyte end-feet
covering intact cerebral capillaries, asterisks are astrocyte bodies,
arrowheads show lumens of capillaries co-opted by the tumours. Figure
S12. Microgliosis around extravasating tumour cells. Arrows show Iba-1-
positive microglia surrounding extravasated tumour cells. Dashed arrow
indicates absence of microglial reaction around the intravascular tumour
cell. Figures S1, S3-5, S3 (2) and S12: confocal z-projection images;
blue = nuclei (Hoechst staining), green = endothelium (YFP), red =
tumour cells (tdTomato), grey = specific stainin. (TIF 49922 kb)
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